| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 202.9 | 155.9 |
| Gross profit | 88.1 | 66.6 |
| Profit before tax | 23.9 | 14.8 |
| Net income | 16.0 | 10.9 |
| EPS (diluted, $ a share) | $0.37 | $0.27 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +46.1% |
|---|---|
| Revenue, year on year | +30.2% |
| Gross margin | 43.4% |
| Operating margin | 14.0% |
10-Q filed with the SEC, NYSE: CDRE. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Cadre Holdings, Inc.: key numbers
- Share price
- $32.10Close, Nov 16
- Market cap
- $1.38B
- Shares outstanding
- 42.92MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & SuppliesSIC 3842
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Cadre Holdings, Inc.
All →Cadre Holdings Leadership Change
Blaine Browers has resigned as Chief Financial Officer of Cadre Holdings, effective December 31, 2026, to pursue other opportunities. The company has appointed Chad Appleby, the current Vice President & Treasurer, to serve as interim CFO starting January 1, 2027, while a permanent successor is sought.
Cadre Holdings Earnings Call: Key Takeaways
Cadre Holdings delivered a strong Q3 2026 beat-and-raise, driven by double-digit organic growth, successful M&A integration, and a new $100 million share buyback program.
- Call
- Nov 5, 2026, 10:00 AM ET
Cadre Holdings Financial Results
Cadre Holdings reported Q3 2026 net sales of $202.9 million, a 30% increase year-over-year, and net income of $16.0 million. The company raised its full-year 2026 guidance for the second consecutive quarter and announced an inaugural $100 million stock repurchase program.
- Term
- Q3 2026
“Our third-quarter results reflect strong execution across Cadre’s businesses, with double-digit organic growth and contributions from acquisitions driving a 30% increase in sales. Net income increased 46% and Adjusted EBITDA margin expanded 110 basis points to 20.2%.”
Warren Kanders, CEO and Chairman
“Heightened geopolitical uncertainty, evolving public-safety requirements and investment in nuclear infrastructure create enduring demand drivers for our mission-critical products. Against this backdrop, healthy customer demand and another quarter of better-than-expected results support our decision to again raise full-year guidance.”
Warren Kanders, CEO and Chairman